News & Stories
2025

News
HKUST and Tsinghua Sign Three Agreements to Deepen Collaboration on Research and Education
The Hong Kong University of Science and Technology (HKUST) signed three agreements with Tsinghua University (Tsinghua) to foster collaboration in research and education. These initiatives include launching a joint Integrated Master-PhD Program in Electronic and Computer Engineering, an executive education program and joint research funding.
Unleashing New Opportunities in Education and Research through Collaboration
HKUST Council Chairman Prof. Harry SHUM and HKUST President Prof. Nancy IP recently received a Tsinghua University delegation led by Secretary of the Party Committee Prof. QIU Yong, alongside Tsinghua Council Deputy Chairman Prof. YANG Bin and other senior Tsinghua officials. The delegation witnessed the signing of the agreements between the two institutions. Key initiatives include:
News
Closing Ceremony of The Jockey Club Sustainable Campus Consumer Programme
Funded by The Hong Kong Jockey Club Charities Trust, the Jockey Club Sustainable Campus Consumer Programme (JCSCCP) aims to promote the United Nations Sustainable Development Goal 12: Responsible Consumption and Production. The programme’s closing ceremony was held at The Education University of Hong Kong (EdUHK) Tai Po campus on 29 May 2025.
The JCSCCP was launched in 2021 and concluded in May 2025, with a donation of over HK$15 million by The Hong Kong Jockey Club Charities Trust. The programme was coordinated by the Sustainability/ Net-Zero Office at The Hong Kong University of Science and Technology, was a collaborative endeavour by the eight UGC-funded universities through The Hong Kong Sustainable Campus Consortium (HKSCC). It targeted students in the eight UGC-funded university communities to encourage positive behaviour change in leading a more sustainable lifestyle through various project themes under the three programme pillars. Key initiatives include:

News
HKUST and BYD Establish Joint Laboratory to Pioneer Embodied Intelligence
The Hong Kong University of Science and Technology (HKUST) and BYD Auto Industry Company Limited (BYD) launched the HKUST-BYD Embodied Al Joint Lab. This collaboration aims to accelerate innovation and industrial applications in robotics and smart manufacturing, injecting new momentum into global scientific advancement and industrial transformation.
The agreement was signed by HKUST Vice-President for Research and Development Prof. Tim CHENG and BYD Vice President Mr. LUO Zhongliang, witnessed by HKUST Council Chairman Prof. Harry SHUM and BYD Group Chairman and President Mr. WANG Chuanfu.

Stories
A Path to Global Health Equity: Bridging the Gaps in Healthcare
In a world still grappling with the aftermath of the COVID-19 pandemic, health disparities are widening and healthcare worker shortages persist, revealing vulnerabilities in our health systems. “Yet within all these challenges lie immense opportunities for collaboration and innovation,” noted Professor Nancy IP, President of The Hong Kong University of Science and Technology (HKUST), at the 2025 Asia Summit on Global Health. As a keynote panelist, she asserted that universities can play a pivotal role in shaping a more equitable and sustainable health system.

News
HKUST Receives Generous Donation from Ho Iu Kwong Charity Foundation
The Hong Kong University of Science and Technology (HKUST) has received a generous donation from the Ho Iu Kwong Charity Foundation (the Foundation) to enhance student development and campus life. In appreciation of this benevolent support, HKUST has named the UG Student Hall III in honor of Mr. Ho Iu Kwong and his wife, Ms. Kwok Pui Chun.
Mr. HO Sai-Chu, eldest son of the late philanthropist and Chairman of the Foundation, attended the naming and plaque unveiling ceremony for the Ho Iu Kwong and Kwok Pui Chun Hall, joined by his family members, the Foundation’s representatives, and HKUST senior management. The late Mr. HO Iu Kwong, founder of Fook Lee Construction Company Ltd, was a distinguished business figure who made significant contributions to education and society.
News
HKUST Showcases Leadership in Med-Tech and AI at Asia Summit on Global Health
The Hong Kong University of Science and Technology (HKUST) showcased its groundbreaking advancements in medical technology and thought leadership at the 2025 Asia Summit on Global Health (ASGH) today. As the event’s exclusive Thematic Session and Health Innovation Partner, HKUST highlighted how technology and collaboration can create a more equitable and sustainable healthcare system for hundreds of participants, including policymakers, healthcare experts, industry leaders, start-ups and investors from around the globe.

News
HKUST-Nurtured Healthtech Startups PanopticAI and SmartCare Partner with Gleneagles Hospital Hong Kong to Pioneer AI-Driven Patient Care Solutions
Two healthtech innovators nurtured by The Hong Kong University of Science and Technology (HKUST) - PanopticAI Limited (PanopticAI) and SmartCare Technology Co Limited (SmartCare), have entered a landmark collaboration with Gleneagles Hospital Hong Kong (Gleneagles). Witnessed by Prof. Nancy IP, President of HKUST; Dr. Prem Kumar NAIR, Group Chief Executive Officer of IHH Healthcare; and Dr. Patrick LAU, Deputy Executive Director of Hong Kong Trade Development Council (HKTDC), the tripartite collaboration agreement signing marks a strategic effort to deploy AI-powered smart clinic solutions at Gleneagles MediCentre, set to launch in late 2025. The partnership exemplifies the commitment of both HKUST and Gleneagles to translating research excellence into real-world applications with a view to facilitating healthcare advancements through the University’s robust entrepreneurship ecosystem.
News
HKUST Partners with Two Leading Shandong-Listed Pharma Companies
香港科技大學(科大)近日與山東兩大醫藥上市公司:綠葉製藥集團(綠葉製藥)與博安生物技術股份有限公司(博安生物)簽署合作協議,共同推動生物醫藥領域的前沿協作、成果轉化及人才培育,以支持科大發展醫療科技及申辦「香港生命健康研發院」等策略舉措。
深化前沿醫藥研究及人才培育合作
綠葉製藥是專注於創新藥物研發的領先中國醫藥企業,近年於中國內地、歐美、日本等主要醫藥市場成功上市13款新藥,在中樞神經系統(CNS)治療領域居領先地位。其子公司博安生物則是一家全面綜合性生物製藥公司,特別聚焦研發腫瘤、自身免疫、眼科和代謝疾病新藥及治療方法。根據協議內容,科大將與兩所企業就臨床前及臨床研究、前沿科學領域探索、人才培訓及交流和科研成果産業化等範疇展開深度協作。
其中,科大與博安生物將特別聚焦開發新型抗癌藥物和癌症新療法;與綠葉製藥則會集中研究神經科學與中樞神經系統疾病的新療法,以及先進藥物遞釋系統。此外,兩家企業亦將支持科大培育醫藥創新領域人才,為學生提供研究和實踐的產業基地,並提供相關科研技術落地應用平台。
科大副校長(研究及發展)鄭光廷教授樂見與兩間公司達成多領域合作,他表示:「科大一直致力推動科研成果產業化,積極搭建從實驗室走向市場的完善產業鏈。我們長期深耕生物醫藥領域的創新研究,近年更積極拓展醫療創新合作網絡。我們期待,透過結合AI與生物醫學的交叉優勢,科大可與兩家企業攜手協作,進一步推高產業化能力,並共同探索智能藥物開發、數據驅動的臨床研究等前沿方向,加速創新成果落地轉化,為全球帶來更精準、高效的醫療方案。」